Search clinical trials for: Iressa
Total 202 results
-
AstraZenecaWithdrawnMetastatic Colorectal CancerItaly
-
AstraZenecaCompletedHead and Neck CancerSpain
-
AstraZenecaCompletedSquamous Cell Carcinoma of the Head and NeckCroatia, Sweden, United States, Czech Republic, Italy, Russian Federation, South Africa, Spain, United Kingdom, Estonia, Latvia, Lithuania, Norway, Canada, Netherlands, Argentina, Belgium, Greece, Thailand, India, Israel, Malaysia, ... and more
-
AstraZenecaWithdrawnHead and Neck Cancer | Carcinoma, Squamous CellItaly
-
AstraZenecaCompletedLocally Advanced Prostate CancerNorway
-
AstraZenecaCompleted
-
AstraZenecaCompletedHead and Neck CancerSwitzerland
-
Fudan UniversityUnknownNon-small Cell Lung Cancer | ToxicityChina
-
Stanford UniversityAstraZeneca; Ligand PharmaceuticalsCompleted
-
AstraZenecaCompletedPulmonary CancerKorea, Republic of
-
AstraZenecaCompletedNon-small Cell Lung CancerChina
-
Samsung Medical CenterUnknownNon-small Cell Lung CancerKorea, Republic of
-
Taipei Veterans General Hospital, TaiwanCompleted
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham...CompletedMetastatic Pancreatic CarcinomaUnited States
-
Dartmouth-Hitchcock Medical CenterNational Cancer Institute (NCI); Norris Cotton Cancer CenterCompletedBreast CancerUnited States
-
AstraZenecaCompletedNeoplasms, Squamous CellUnited States, Czech Republic, Poland, Germany, Belgium, Taiwan, India, Serbia
-
AstraZenecaTerminatedBrain Neoplasms | Non Small Cell Lung CancerItaly
-
National Taiwan University HospitalUnknownNon-Small Cell Lung CancerTaiwan
-
AstraZenecaCompletedCancer of Head and NeckSpain
-
AstraZenecaCompletedBreast CancerSweden, Czech Republic, France, Spain, United Kingdom, Hungary, Portugal
-
AstraZenecaCancer International Research Group (CIRG)CompletedBreast Cancer
-
AstraZenecaCompletedNon-Metastatic Prostate CancerFinland
-
AstraZenecaCompleted
-
AstraZenecaCompletedCancer of Head and Neck | Squamous Cell CancerUnited Kingdom
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon-Small-Cell Lung CarcinomaCzech Republic, Italy, Korea, Republic of, South Africa, United Kingdom, Germany, Australia, Taiwan, France, Brazil
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompletedNSCLCSweden, Bulgaria, Mexico, Russian Federation, Turkey, United Kingdom, Philippines, Malaysia, Germany, Hungary, Latvia, Lithuania, Poland, Romania, Netherlands, Norway, Argentina, Australia, Canada, Slovakia, Greece, Taiwan, Thailand, ... and more
-
AstraZenecaCompleted
-
Fudan UniversityUnknownCarcinoma, Non-Small-Cell LungChina
-
AstraZenecaCompleted
-
University Hospital of CreteCompleted
-
AstraZenecaCompletedSmall Cell Lung CancerUnited Kingdom, Denmark
-
University Hospital, ToulouseCompletedParkinson's DiseaseFrance
-
Guangdong Provincial People's HospitalUnknownNon-Small Cell Lung Cancer | Brain Metastasis
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
AstraZenecaCompletedHead and Neck CancerHong Kong, Singapore
-
AstraZenecaCompleted
-
AstraZenecaCompletedNon Small Cell Lung CarcinomaAustralia
-
AstraZenecaCompleted
-
AstraZenecaCompletedMetastatic Breast CancerNorway
-
AstraZenecaCompletedGefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerHead and Neck NeoplasmsFinland
-
NSABP Foundation IncAstraZenecaCompletedBreast NeoplasmsUnited States
-
University of ZurichCompletedRecurrent GlioblastomaSwitzerland